N

Nizam's Institute of Medical Sciences | Neurology Department

Research site
(Unclaimed)
Location
Millennium Block, Ground Floor, Panjagutta, Hyderabad, Telangana, India
Site insights

Top conditions

Kidney Diseases (3 trials)

Non-Small-Cell Lung Carcinoma (3 trials)

Breast Cancer (2 trials)

Parkinson Disease (2 trials)

Diabetes Mellitus (2 trials)

Top treatments

Safinamide
Nintedanib
Warfarin
Dabigatran Etexilate
Dabigatran
Finerenone
Eteplirsen
Levodopa
MOTION
Letrozole

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

5 of 29
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer (EMBER-4)

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cance...

Enrolling
Breast Neoplasms
Drug: Letrozole
Drug: Tamoxifen

The purpose of this study is to assess if adding LY3537982 in combination with standard of care anti-cancer drugs is more effective than standard of...

Enrolling
Carcinoma, Non-Small-Cell Lung
Neoplasm Metastasis
Drug: Pemetrexed
Drug: LY3537982

This study will be comprised of 2 parts: Part 1 (dose escalation) will be conducted to evaluate the safety and tolerability of 2 doses (100 milligram...

Active, not recruiting
Muscular Dystrophy, Duchenne
Drug: Eteplirsen

Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys' ability to work pr...

Enrolling
Chronic Kidney Disease
Type 2 Diabetes Mellitus
Drug: Finerenone (Kerendia, BAY94-8862)

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with...

Enrolling
Chronic Kidney Disease
Inflammation
Drug: Ziltivekimab C
Drug: Placebo (Ziltivekimab B)

Trial sponsors

Boehringer Ingelheim logo

Boehringer Ingelheim (5 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems